19 May 2017 | News
The 2017 European CEO Awards recognizes Dr. Cutler for his leadership in pivotal clinical trials and his success as a clinical researcher and honors him with the title of Best CEO in the CRO industry.
Dr. Neal Cutler
Dr. Neal Cutler, M.D. is the Chief Executive Officer of Worldwide Clinical Trials, a company focused on the development of life-changing medicines, which is recognized by organizations from around the world for its outstanding services and expertise in clinical trials. It has won various awards which include Informa’s Scrip Award, Life Science Leader’s CRO Leadership Award, Nice Insight etc.
This honor recognizes Dr. Cutler’s contributions as the founder and CEO of Worldwide, one of the world’s leading, full-service contract research organizations (CROs). The annual European CEO Awards highlight the achievements of CEOs across a variety of industries whose contributions are driving their companies forward.
Dr. Cutler, a board-certified psychiatrist who is also board-qualified in both neurology and clinical pharmacology, has been instrumental in the design and clinical development of nearly 200 compounds in numerous therapeutic areas. Since creating the first iteration of Worldwide Clinical Trials 30 years ago, he has guided the company with a steadfast commitment to the medicine and science of clinical research, leading to impressive growth. This, along with his consistent dedication to Worldwide’s customers, were named as key reasons for his receiving the European CEO Award.
“I am humbled to have been recognized with this prestigious honor. This truly is a reflection of what Worldwide has achieved, and the high-quality service that we consistently deliver – I share this award with our amazing team,” said Dr. Cutler in a press release. “My passion for the potentially life-changing work Worldwide does every day drives me and shapes my leadership, and it is this passion that I share with our entire company. This drive to support our sponsor partners in drug discovery permeates our company and has helped build our reputation as one of the world’s leading CROs.”
Dr. Cutler has authored 276 publications, including nine books on the topics of clinical pharmacology, aging, Alzheimer’s disease, schizophrenia, anxiety disorders and diabetes. He has been a prominent figure in the industry, having been invited to give hundreds of presentations around the world in the fields of aging, clinical pharmacology and drug development.
The European CEO Awards recognize the leading players across a range of sectors, the companies pushing the envelope in business, and the executives who make this progress possible. Dr. Cutler joins other recent healthcare industry winners including the CEOs of Chronos Therapeutics, Biolingus, and Evaxion Biotech.